Monday, 5 August 2013

CDER New August 5, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 2, 2013


New and Generic Drug Approvals

August 1, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Altabax retapamulin Ointment; Topical Glaxo Grp Ltd Manufacturing Change or Addition
Amaryl glimepiride Tablet; Oral Sanofi Aventis Us Labeling Revision
Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol desogestrel; ethinyl estradiol; ethinyl estradiol Tablet; Oral Novast Labs Ltd Approval
Ditropan Xl oxybutynin chloride Tablet, Extended Release; Oral Janssen Pharms Labeling Revision
Galzin zinc acetate Capsule; Oral Teva Manufacturing Change or Addition
Glimepiride glimepiride Tablet; Oral Hikma Pharms Approval
K-Tab potassium chloride Tablet, Extended Release; Oral Abbvie Manufacturing Change or Addition
Norethindrone norethindrone Tablet; Oral Haupt Pharma Approval
Orap pimozide Tablet; Oral Teva Manufacturing Change or Addition
Potassium Chloride potassium chloride Tablet, Extended Release; Oral Abbvie Manufacturing Change or Addition

 


This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

No comments:

Post a Comment